ABSTRACT The Ca 2þ channel a 1S subunit (Ca V 1.1) is the voltage sensor in skeletal muscle excitation-contraction (EC) coupling. Upon membrane depolarization, this sensor rapidly triggers Ca 2þ release from internal stores and conducts a slowly activating Ca 2þ current. However, this Ca 2þ current is not essential for skeletal muscle EC coupling. Here, we identified a Ca V 1.1 splice variant with greatly distinct current properties. The variant of the CACNA1S gene lacking exon 29 was expressed at low levels in differentiated human and mouse muscle, and up to 80% in myotubes. To test its biophysical properties, we deleted exon 29 in a green fluorescent protein (GFP)-tagged a 1S subunit and expressed it in dysgenic (a 1S -null) myotubes. GFP-a 1S D29 was correctly targeted into triads and supported skeletal muscle EC coupling. However, the Ca 2þ currents through GFP-a 1S D29 showed a 30-mV left-shifted voltage dependence of activation and a substantially increased open probability, giving rise to an eightfold increased current density. This robust Ca 2þ influx contributed substantially to the depolarization-induced Ca 2þ transient that triggers contraction. Moreover, deletion of exon 29 accelerated current kinetics independent of the auxiliary a 2 d-1 subunit. Thus, characterizing the Ca V 1.1D29 splice variant revealed the structural bases underlying the specific gating properties of skeletal muscle Ca 2þ channels, and it suggests the existence of a distinct mode of EC coupling in developing muscle.
INTRODUCTION
The voltage-gated Ca 2þ channel Ca V 1.1 functions as a voltage sensor in skeletal muscle excitation-contraction (EC) coupling. It is located in triad junctions in close apposition to the Ca 2þ release channel (type 1 ryanodine receptor (RyR1)) in the sarcoplasmic reticulum (SR). On depolarization of the surface membrane, Ca V 1.1 undergoes a conformational change that rapidly activates the Ca 2þ release channel, presumably via protein-protein interactions. Ca 2þ influx through the voltage-gated Ca 2þ channel is not required for activation of skeletal muscle EC coupling. As a matter of fact, L-type Ca 2þ currents through Ca V 1.1 activate very slowly and at more positive membrane potentials than EC coupling (for review, see Melzer et al. (1) ). Therefore, it is unlikely that during a short skeletal muscle action potential Ca 2þ channels contribute significant amounts of Ca 2þ to the transients that trigger contraction.
Multiple splice variants greatly enrich the functional diversity of the CACNA1 gene family and the splicing patterns are conserved across different members of this gene family and across various species (2) . Splicing has been extensively studied for the cardiac Ca V 1.2 encoded by CACNA1C (3) (4) (5) (6) (7) (8) and for the neuronal Ca V 2.1 (CAC-NA1A) and Ca V 2.2 (CACNA1B) (9) (10) (11) . In contrast, only one Ca V 1.1 splice variant has so far been described in rabbit skeletal muscle. Skipping of exon 29 (5) shortens the extracellular loop connecting transmembrane domains IVS3 and IVS4. This loop is a conserved splicing site of Ca V 1 a 1 subunits that has been shown to generate differentially distributed and functionally distinct channel variants. For example, the Ca V 1.3 and Ca V 2.2 IVS3-IVS4 splice variants are expressed in different regions of the cardiovascular system and the nervous system, respectively (11, 12) , and skipping of the corresponding exon in the smooth muscle variant of Ca V 1.2 resulted in a channel with increased voltage and drug sensitivity (13) . For the skeletal muscle Ca V 1.1, the functional consequence of exon skipping in IVS3-IVS4 or the specific expression patterns of this splice variant have hitherto not been analyzed.
In this study, we describe Ca V 1.1 splice variants transcribed in human adult muscle and in muscle cell cultures. Because the variant lacking exon 29 (Ca V 1.1D29) was predicted to code for a functional channel and was abundantly expressed in myotubes, we performed a thorough analysis of its biophysical properties. Reconstitution of dysgenic (Ca V 1.1-null) myotubes with Ca V 1.1D29 fully restored skeletal muscle EC coupling, however, with Ca 2þ currents eight times larger and activating at 30 mV less depolarizing potentials than Ca V 1.1 with exon 29. Thus, the analysis of the Ca V 1.1D29 splice variant identified the IVS3-IVS4 loop as the structural basis of the weak voltage sensitivity of the full-length skeletal muscle Ca 2þ channels. Furthermore, our results indicate that in muscle cells expressing this newly characterized channel variant, Ca 2þ influx contributes significantly to the cytoplasmic Ca 2þ signal that triggers skeletal muscle contraction.
MATERIALS AND METHODS

Detection of splice variants
Muscle biopsies (Vastus lateralis of five control subjects with their informed consent) were shredded and trypsinized for 30 min at 37 C. Satellite cells were isolated by filtration (nylon filter, 0.22 mm) and cultured in skeletal muscle growth medium (PromoCell, Heidelberg, Germany). After 10-14 days, the medium was changed to a differentiation medium (PromoCell). Mature myotubes (those with more than five nuclei) were obtained after an additional 1-2 weeks. Total RNA was extracted from homogenized mouse muscle tissues and cultured myotubes using TRIzol reagent (Gibco BRL, Gaithersburg, MD) according to the manufacturer's protocol. Reverse transcription polymerase chain reaction (RT-PCR) amplification was carried out with a one-step RT-PCR kit (Qiagen, Hilden, Germany) and overlapping primer pairs (see Table S3 in Supplementary Material). DNA fragments of splice variants were separated by 2% agarose gel electrophoresis and stained with ethidium bromide (0.7 mg/ml). Size and intensity of PCR bands were quantified using Scion Image 4.0.3.2 (Scion, Frederick, MD). DNA sequences of splice variants were confirmed sequencing (BIG Dye Terminator Cycle Sequencing Kits, Applied Biosystems, Foster City, CA).
Quantitative TaqMan PCR
Total RNA was isolated from differentiated myotubes from a skeletal muscle cell line derived from H2-KB-TSA58 mice (Immortomice (14, 15) ) using the RNeasy Mini kit (Qiagen) and reverse-transcribed (SuperScriptII, Invitrogen, Carlsbad, CA). The relative abundance of Ca V 1.1 and Ca V 1.1D29 mRNAs was assessed by TaqMan quantitative PCR (50 cycles) using a standard curve method based on PCR products of known concentrations (16) . TaqMan gene expression assays, designed to span exon-exon boundaries (Table S3) , were purchased from Applied Biosystems. cDNA concentrations of the three individual experiments were comparable, as revealed by the expression of seven different reference genes (b-actin, B2M, GAPDH, HPRT1, Tbp, Tfrc, and SDHA). Analyses were performed using the 7500 Fast System (Applied Biosystems).
Expression plasmids
Bases 3609-3666, corresponding to exon 29, were deleted from GFP-a 1S (17) by PCR splicing using a primer pair encompassing restriction sites upstream (XhoI) and downstream (BglII) of exon 29 (P1 and P2 (Table  S3) ), and two complementary primers each consisting of the end sequence of exon 28 joined to the start sequence of exon 30 (P3 and P4 (Table  S3) ). a 2 d-1 shRNA expression plasmid has been previously published (18) .
Cell culture and transfections
Myotubes of the homozygous dysgenic (mdg/mdg) cell line GLT were cultured and transfected as previously described (19) . Myotubes were analyzed 3-5 days after transfection.
Immunofluorescence and antibodies
Immunofluorescence analysis was performed as described (20) , using the following antibodies: rabbit polyclonal anti-GFP (1:4000, Molecular Probes, Eugene, OR); mouse monoclonal anti-RyR (34-C, 1:1000, Alexis Biochememicals, Lausen, Switzerland); secondary goat-anti-mouse Alexa-594 and goat-anti-rabbit Alexa-488 (1:4000, Molecular Probes). Images were captured on a Zeiss Axiophot microscope with a cooled CCD camera and METAVUE image-processing software (Universal Imaging, West Chester, PA). The current-voltage dependence was fitted according to
where G max is the maximum conductance of the L-type Ca 2þ channels, V rev is the extrapolated reversal potential of the Ca 2þ current, V 1/2 is the potential for half-maximal conductance, and k is the slope.
The voltage dependence of the Ca 2þ conductance, ''On'' gating charge movement, and Ca 2þ transients were fitted according to a Boltzmann distribution:
The kinetic properties of the Ca 2þ current activation were determined by fitting the rising phase of the maximum sweep (þ40 or þ50 mV for GFP-a 1S and þ10 or þ20 mV for GFP-a 1S D29 and GFP-a 1S D29 þ a 2 d-1 siRNA) with a single-or double-exponential function:
where I is the current; A fast , A slow , and A mono are the individual current amplitudes; and t fast , t slow , and t mono are the specific time constants of the current amplitudes.
RESULTS
Human and mouse skeletal muscles express transcripts of multiple Ca V 1.1 splice variants
To determine the genetic variability of the skeletal muscle voltage-gated Ca 2þ channel, we performed an RT-PCR screen for Ca V 1.1 splice variants on RNA from human and mouse muscle and cultured myotubes. We identified nine rare variants coding for nonsense proteins, each of which made up <3% of transcripts in myotubes and muscle (Table  S1 and Fig. S1 ). Eight of these produced frame shifts resulting in premature stops, precluding formation of functional channels. The ninth, a deletion of exon 19, lacks almost an entire transmembrane segment and would thus invert the transmembrane orientation of the channel distal to IIIS1. Most likely, all of these transcripts are subject to nonsensemediated decay, a process that affects transcripts with premature termination codons (21) .
Further, we identified three C-terminal Ca V 1.1 variants, all of which code for truncated but putatively functional proteins (Table S2) a premature stop after only three residues. Alternative 5 0 splicing of exon 40 results in the in-frame deletion of 26 residues in positions 1599-1625. The insertion of intron 43 generates a protein with 61 residues at the C-terminus. Because the distal end of the channel has previously been shown to exert an autoinhibitory effect on gating charge movements and Ca 2þ currents (22) , all three C-terminal variants are expected to result in a gain of function similar to an artificial truncation at position 1698. Transcripts of all three C-terminal variants were expressed in low abundance.
Finally, the RT-PCR screen revealed an in-frame deletion of exon 29 (D29) (Fig. 1 A) that encodes a 1854-amino-acid protein lacking 19 residues in the extracellular loop between transmembrane segments IVS3 and IVS4 (Fig. 1 B) . This Ca V 1.1 variant had previously been identified in mouse ovaries, in the BC3H1 cell line (5), and in rat osteosarcoma cells (23) . Quantifying the RT-PCR bands of the full-length and splice-variant Ca 2þ channels showed that Ca V 1.1D29 was expressed at low levels in differentiated muscles from man and mouse (2-10% of transcripts), but was abundant in primary human myotubes and in the C 2 C 12 mouse muscle cell line (60-80% of transcripts ( Fig. 1 C) ). Taqman RT-PCR, using assays spanning the borders between exons 28-29 and exons 28-30 (Table S3) , confirmed the high expression levels of Ca V 1.1D29 in an additional skeletal muscle cell line. Of the Ca V 1 transcripts in RNA from myotubes derived from the Immortomouse, 77 5 3% lacked exon 29 ( Fig. 1 D) . Together, these data show that Ca V 1.1D29 is the predominant Ca V 1.1 isoform in skeletal myotubes. Analogous splice variants in other L-type Ca 2þ channel a 1 subunits code for functional channels. Thus, it is likely also that Ca V 1.1D29 is functional and thus may be of physiological relevance.
Ca V 1.1D29 is localized in the EC-coupling apparatus
To analyze the physiological properties of Ca V 1.1D29, we deleted the sequence corresponding to amino acids 1203-1222 in the GFP-tagged Ca V 1.1 a 1S subunit (17) and expressed the resulting construct, GFP-a 1S D29, in dysgenic (a 1S -null) myotubes. Reconstitution of dysgenic myotubes with GFP-a 1S restores normal triad targeting of the GFP-a 1S subunit (Fig. 2, left column) as well as skeletal muscle EC coupling (20) . Double-immunofluorescence analysis of GFP-a 1S D29-transfected myotubes showed that, like the wild-type GFP-a 1S , GFP-a 1S D29 was localized in a clustered pattern that was colocalized with clusters of RyR1 (Fig. 2 , right column). This labeling pattern is typical for triad proteins and indicates that GFP-a 1S D29 is correctly targeted into junctions between the SR and t-tubules or the plasma membrane, and thus can function in EC coupling (20) .
Ca V 1.1D29 has distinct current properties
Whole-cell patch-clamp recordings in dysgenic myotubes reconstituted with GFP-a 1S D29 revealed greatly augmented Ca 2þ currents (Fig. 3 A) . Mean peak current density was increased eightfold from 1.9 5 0.2 pA/pF in GFP-a 1S -expressing myotubes to 14.8 5 1.2 pA/pF in myotubes expressing GFP-a 1S D29 (Fig. 3 B and Table 1) . Moreover, the current-voltage curves showed a greatly increased voltage sensitivity. The half-maximal activation was shifted from 39.1 5 1.3 mV for the wild-type to 9.3 5 1.0 mV for the GFP-a 1S D29 channel (Fig. 3 C) . Because at less positive voltages the driving force for Ca 2þ currents is larger, the left-shifted voltage dependence of activation accounted in part for the observed increase in current density.
To determine whether enhanced membrane expression of Ca 2þ channels also contributed to the increase in current density, we analyzed the charge movements upon channel activation in the presence of Cd 2þ /La 3þ to block the Ca 2þ conductance (Fig. 3 D) . The integral of the immobilization-resistant ''On'' gating charge movement (Q on ) is a measure of functional Ca 2þ channels in the membrane (24) . In myotubes expressing GFP-a 1S or GFP-a 1S D29, Q on was not significantly different at any voltage (Fig. 3 E) , indicating that membrane expression of functional Ca 2þ channels was not changed in the variant lacking exon 29. Alternatively, altered single-channel conductance could be responsible for the increased current density. Therefore, we analyzed the tail currents at the end of 200-ms test pulses to near the reversal potential, where a maximal number of channels should be activated (Fig. 3 F) , and we plotted the peak current density of the tail currents against the integral of Q on (25) . The slope of the linear regression was increased from 0.38 5 0.07 (GFP-a 1S ) to 3.59 5 0.89 (GFP-a 1S D29) (Fig. 3 G) . This indicated that deletion of exon 29 caused a significant increase in the relative open probability (P o ) (Table 1) . Together, electrophysiological analyses demonstrated that compared to the full-length isoform, the Ca V 1.1D29 splice variant has a greatly increased voltage sensitivity and open probability, resulting in an eightfold increase of the wholecell Ca 2þ currents.
Ca V 1.1D29 has accelerated current kinetics
Another property of the Ca 2þ current that was altered by the deletion of exon 29 was the speed of activation and inactivation. This is evident in the representative current traces shown in Fig. 3 A. The average time to peak measured in the maximum current traces was significantly reduced from 84.7 5 6.3 ms (GFP-a 1S ) to 39.8 5 4.5 ms (GFPa 1S D29) (Fig. 4 A) . In a similar way, the fractional inactivation at the end of the 200-ms test pulse increased from 4.7 5 1.2% to 23.82 5 2.0% (Fig. 4 B) .
To elucidate the mechanism of Ca 2þ -current acceleration we further analyzed the activation phase by fitting the maximum current traces. Kinetic analysis of GFP-a 1S D29-expressing myotubes using a double-exponential function (26) showed that the majority of the currents consisted of a fast-and a slow-activating component. Whereas the relative abundance of both components (Fig. 4 C) , and the time constant of the fast component, were equal for GFP-a 1S and GFP-a 1S D29, the time constant of the slow component was significantly faster (14.1 5 2.5 ms) compared to that of GFP-a 1S (28.7 5 3.3 ms) (n ¼ 18) (Fig. 4 D and Table 1 ). In addition, activation kinetics of 15 out of 33 currents were best described by a single-exponential function with a time constant equal to that of t fast in the currents with two activation components (Table 1) . Whether this resulted from an even greater acceleration of the slow component or from an almost complete loss of its contribution to the wholecell current cannot be discerned.
Ca V 1.1D29 interacts with the a 2 d-1 subunit Previously, we reported that depletion of the Ca 2þ channel a 2 d-1 subunit with siRNA also accelerated Ca 2þ current kinetics (18) . Therefore, we examined whether GFP-a 1S D29 currents were affected by depletion of a 2 d-1. Fig. 5 A shows that coexpressing dysgenic myotubes with GFP-a 1S D29 and a plasmid coding for a 2 d-1 shRNA further accelerated activation and inactivation of Ca 2þ currents compared to those expressing GFP-a 1S D29 alone. Knock-down of a 2 d-1 showed a 42% decrease in time to peak to 22.9 5 0.1 ms (Fig. 5 B and Table 2) , and a 22% increase in the fractional inactivation to 30.6 5 0.2% (Fig. 5 C) . Moreover, as previously shown for GFP-a 1S , it is also the case with GFP-a 1S D29 that the rising phase of all currents in a 2 d-1-depleted myotubes was best fitted by a single-exponential function (Fig. 5 D) . This indicates that GFP-a 1S D29 still interacted with the a 2 d-1 subunit in skeletal myotubes. Furthermore, immunocytochemical analysis demonstrated that the deletion of exon 29 did not affect triad targeting of the a 2 d-1 subunit (Fig. S2) . Thus, the mechanisms by which the IVS3-IVS4 loop and the a 2 d-1 subunit regulate activation kinetics are independent of each other.
Ca V 1.1D29 supports skeletal muscle EC coupling with a substantial component of Ca 2þ influx Ca V 1.1 Ca 2þ currents activate slowly and at much higher membrane potentials than depolarization-induced Ca 2þ release from the SR. As a consequence, Ca 2þ influx through the Ca V 1.1 Ca 2þ channel does not essentially contribute to skeletal muscle EC coupling (1) . However, the current properties of GFP-a 1S D29 described above resemble much more those of the cardiac Ca V 1.2, which activates EC coupling by Ca 2þ -induced Ca 2þ release (27) . Therefore, it was important to determine whether GFP-a 1S D29 can trigger EC coupling in skeletal myotubes, and if so, by which mechanism. To this end, we measured Ca 2þ transients during patch-clamp experiments using the fluorescent Ca 2þ indicator Fluo-4. Fig. 6 A shows that during a depolarizing pulse, GFP-a 1S D29-expressing myotubes give rise to Ca 2þ transients, indicating that GFP-a 1S D29 can activate EC coupling. Because of its independence of Ca 2þ influx, skeletal muscle EC coupling remains fully activated at test pulses to near the reversal potential. Therefore, in myotubes expressing GFP-a 1S , the voltage-dependence curve of Ca 2þ transients has the characteristic sigmoidal shape (Fig. 6 B, squares) . The voltagedependence curve of transients in GFP-a 1S D29 expressing myotubes peaks earlier and at a higher level than that of GFP-a 1S before it declines to the same level as that of GFP-a 1S (Fig. 6 B (gray stars) and Table 3 ). The fact that at the reversal potential GFP-a 1S D29 still activates solid Ca 2þ transients demonstrates that it supports the skeletal muscle EC coupling mechanism. The early-activating additional component is likely caused by Ca 2þ entering the myotubes from the outside through the Ca V 1.1D29 channel. Indeed, blocking Ca 2þ currents with Cd 2þ /La 3þ abolished the early peak of the voltage-dependence curve so that it exactly matched that of the full-length GFP-a 1S isoform (Fig. 6 B, open stars) .
DISCUSSION
Here, we report the first functional characterization of a splice variant of the skeletal muscle voltage-gated Ca 2þ channel, and the extent to which the channel properties of Ca V 1.1D29 differ from those of the classical full-length Ca V 1.1 is amazing. Ca V 1.1D29 is normally targeted into the triads and supports skeletal muscle type EC coupling, but the lack of exon 29 causes drastically increased voltage sensitivity and open probability of the channel. Alternative splicing of the extracellular loop between transmembrane segments 3 and 4 in the fourth homologous repeat has also been described in other L-type and non-L-type Ca 2þ channels (5, 7, (9) (10) (11) 13, 23) . It is interesting to note that in all these cases, changes in the length of the IVS3-IVS4 linker were accompanied by changes in the voltage dependence of activation. In Ca V 1.2, 12 possible splicing combinations exist in this domain, four of which have been functionally characterized. The IVS3-IVS4 loop of variant A was shortened by 13 amino acids and the potential of half-maximal activation (V 1/2 ) was left-shifted by À9.5 mV; that of variant B was 6 residues shorter, with V 1/2 shifted by À4.9 mV; and that of variant C was 11 residues shorter, with V 1/2 shifted by À6.8 mV.
In variant D, a 12-amino-acid sequence was exchanged without changing the total length of the IVS3-IVS4 loop, and the voltage sensitivity remained unaltered (7) . Here, we demonstrate that the lack of exon 29 in Ca V 1.1D29, which shortens the IVS3-IVS4 loop by 19 amino acids, leads to a À29.8 mV shift of the voltage dependence of activation. Together, these observations suggest an inverse correlation of the length of the IVS3-IVS4 loop and the voltage sensitivity of Ca 2þ -channel splice variants. From a mechanistic perspective, it All data are presented as mean 5 SE.
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is conceivable that a shorter IVS3-IVS4 loop pulls the positively charged voltage sensor IVS4 toward the extracellular side of the membrane and thus facilitates its transition into the activated state upon depolarization. This would result in an increased voltage sensitivity and an increased dwell time in the open state.
The distinguishing characteristics of the skeletal muscle Ca 2þ current are its extremely slow activation kinetics and activation at very positive potentials. Using skeletal/cardiac muscle Ca V 1 chimeras, a sequence including transmembrane domain S3 and the S3-S4 loop of the first repeat was shown to determine the slow gating mode (28) . The results of this study demonstrate the importance of a separate domain, the IVS3-IVS4 loop, for the characteristic voltage dependence of activation of Ca V 1.1. Indeed, Nakai et al. (28) reported that in their chimeras, the slow and fast kinetics did not correlate with low and high voltage sensitivity, respectively. Our study provides independent evidence that voltage sensitivity and activation kinetics are determined by separate mechanisms. We have shown previously that the auxiliary a 2 d-1 subunit is an important determinant of the slow activation of Ca V 1.1, and that shRNA depletion of a 2 d-1 accelerated current activation by increasing the population of fast-activating channels at the expense of slowactivating channels (18) . The voltage sensitivity of activation was not altered by a 2 d-1 siRNA treatment. Although the removal of exon 29 also accelerated activation kinetics, this resulted from a reduced time constant of the slow-activating component. Moreover, Ca V 1.1D29 channels were still sensitive to depletion of a 2 d-1, which caused an additional increase in activation kinetics. Thus, two separate sequences in the corresponding domains of the first and fourth repeats of Ca V 1.1 are responsible for the characteristic kinetics and voltage dependence of activation, respectively. Whereas IS3 and the IS3-IS4 loop appear to cooperate with the a 2 d-1 subunit in determining the activation kinetics, the length of the IVS3-IVS4 loop determines the voltage sensitivity of Ca V 1.1.
It is interesting that the deletion of exon 29 only affected the voltage sensitivity of the Ca 2þ current, but not that of the ''On'' gating charges and Ca 2þ transients, which activate at similarly low potentials in Ca V 1.1 and Ca V 1.1D29. Thus, the long IVS3-IVS4 loop, and with it the voltage sensor of repeat 4, is rate-limiting for activation of the Ca 2þ current release, but the gating of all four voltage sensors is necessary for activation of the Ca 2þ current, a single less responsive voltage sensor would be enough to delay current activation. However, since the voltage sensors of repeats I and IV appear to be involved in controlling the kinetics and voltage sensitivity of the current, respectively, the two other voltage sensors, those of repeats II and III, which flank the cytoplasmic loop that interacts with the RyR1, may be sufficient for the rapid activation of EC coupling. If, however, the short IVS3-IVS4 loop would hold the voltage sensor of repeat IV in a constitutively activated position, a reduction of Q on by one-fourth would have been expected in Ca V 1.1D29. This was not observed. Therefore, the shorter IVS3-IVS4 loop appears to enhance the coupling between the voltage-dependent step and the final voltage-independent step of channel gating.
We further demonstrate that transcripts of the Ca V 1.1 splice variant lacking exon 29 (Ca V 1.1D29) are expressed in human and mouse muscles and that Ca V 1.1D29 is the predominant isoform in human and mouse cultured myotubes. If this is so, Ca 2þ currents in normal myotubes like the C 2 C 12 cell line, which express a mix of Ca V 1.1 and Ca V 1.1D29, should have an intermediate voltage sensitivity compared to dysgenic myotubes expressing either GFP-a 1S or GFP-a 1S D29. Indeed, this was observed in two previous studies by Schuhmeier et al. (30, 31) , who determined the voltage sensitivity of Ca 2þ currents and Ca 2þ transients in reconstituted dysgenic myotubes and in C 2 C 12 myotubes. Consistent with the data presented here, in dysgenic myotubes transfected with GFP-a 1S , half-maximal activation of Ca 2þ currents occurred at~30 mV higher potentials than activation of Ca 2þ transients. In contrast, this difference was only~15 mV in C 2 C 12 cells. Thus, the current properties of cultured myotubes most likely reflect the properties of a mixed population of Ca V 1.1 splice variants.
Finally, Ca V 1.1D29 was correctly incorporated into triad junctions and supported skeletal muscle type EC coupling, although the highly increased voltage sensitivity and amplitude of Ca 2þ currents altered the EC coupling properties. Dysgenic myotubes exclusively expressing the GFPa 1S D29 isoform showed depolarization-dependent Ca 2þ transients, which did not require Ca 2þ influx through the channel. In addition, the rapidly activating Ca 2þ current contributed significant amounts of Ca 2þ to the cytoplasmic Ca 2þ transients. Under physiological conditions, this component will be diminished by the presence of the full-length Ca V 1.1. Nevertheless, the additional Ca 2þ influx is expected to increase the force of contraction and it creates the need for increased export of Ca 2þ from the cell to maintain equilibrium. The observation that Ca V 1.1D29 transcripts were highly expressed in cultured myotubes from humans and mice suggests a physiological role of this splice variant in developing and regenerating muscle. It is plausible that myotubes with an incompletely differentiated SR Ca 2þ storage and release apparatus require more Ca 2þ influx and rely part on a cardiac-like EC coupling mechanism. Moreover, given the great variety of muscle types in our body it is intriguing to consider the possibility that Ca V 1.1D29 may also play a role in some type of differentiated muscle. Finally, Ca V 1.1 mutants affecting Ca 2þ current properties have been linked to human disease, but the effects of these disease mutants on EC coupling were small (32, 33) . In light of the existence of a splice variant with dramatically different current properties and its possible function during development, the effects of these disease mutations on this splice variant, as well as the possible pathological consequences, need to be investigated.
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